Addus HomeCare (ADUS) Stock Analysis & AI Equity Report

Medical - Care Facilities USD Explore free reports

Addus HomeCare (ADUS) overview

Addus HomeCare (ADUS) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 1,423m and operating profit of USD 139m; the year-end share price was 107.39 USD and market capitalisation was USD 1,989m. Addus HomeCare is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Addus HomeCare's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 1,085mFY 2025
Share price107.39 USDFY 2025 year end
RevenueUSD 1,423mFY 2025
Operating profitUSD 139mFY 2025
Net earningsUSD 95.9mFY 2025
Market capitalisationUSD 1,989mFY 2025 year end

About Addus HomeCare

Addus provides personal care, hospice, and home health services, principally in consumers’ homes. Personal care supports daily living activities, while hospice and home health provide clinical care. The company serves older adults and other adults requiring long-term care, including many eligible for both Medicare and Medicaid. Its customers and funding partners include government agencies, managed care organizations, commercial insurers, and private individuals.

Generate the Addus HomeCare report

Addus HomeCare is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Addus HomeCare and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Addus HomeCare

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.